# GREFI – FDA Inspection, Oct 1, 2019

Source: https://www.keypedia.com/records/fda_inspections/grefi/f0bd9547-c9d4-4513-bd6e-1d85bd384b25
Source feed: FDA_Inspections

> FDA inspection 1101917 of GREFI, October 01, 2019. Classification: Official Action Indicated (OAI). 5 citations under 21 CFR part 1271. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101917
- Company Name: GREFI
- Inspection Date: 2019-10-01
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1145211 - 2021-06-14](https://www.keypedia.com/records/fda_inspections/grefi/eb7626ec-a116-45d8-bc40-860396419a66)
- [FDA Inspection 1048379 - 2018-04-05](https://www.keypedia.com/records/fda_inspections/grefi/63befdfa-b892-4a51-a280-f62023950dfc)
- [FDA Inspection 941188 - 2015-08-31](https://www.keypedia.com/records/fda_inspections/grefi/9a532bda-b659-4cec-a304-f075518e0336)

Company: https://www.keypedia.com/companies/grefi/83794621-4501-476a-b8da-1193825d6326

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d